Neogenomics (NEO) Other Non-Current Assets (2010 - 2026)

Neogenomics (NEO) has 16 years of Other Non-Current Assets data on file, last reported at $9.3 million in Q2 2026.

• Quarterly Other Non-Current Assets rose 30.64% year-over-year to $9.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.3 million (up 30.64% YoY) and the FY2025 annual result came in at $9.3 million, up 58.68% from the prior year.
• Other Non-Current Assets slipped to $9.3 million in Q2 2026, from $9.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $9.6 million in Q1 2026 to a low of $4.1 million in Q2 2024.
• A 5-year average of $6.4 million and a median of $5.9 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 40.64% — and 2025, when it jumped 74.9%.
• Tracing NEO's Other Non-Current Assets over 5 years: stood at $5.1 million in 2022, then retreated by 7.18% to $4.7 million in 2023, then grew by 24.12% to $5.9 million in 2024, then soared by 58.68% to $9.3 million in 2025, then fell by 0.31% to $9.3 million in 2026.
• The last three Other Non-Current Assets figures came in at $9.3 million (Q2 2026), $9.6 million (Q1 2026), and $9.3 million (Q4 2025), per Business Quant data.